Topic summary

Coming back to: Telehealth prescribing models in the US

Regional › North America telehealth FDA compounding insurance

This is a generated summary. It shows the 5 most-liked posts from a topic of 31, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

t.demirTL26 Jul 2026#7

e.mwangi, post #5: I read the earlier replies on Telehealth prescribing models twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected. Go to post

Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different.

That is the version I use. It may not be the version that is correct.

27 likes in reply to #5 21d

e.lokkenTL210 Jul 2026#10

On post #6 — agreed on the reasoning, with one qualification.

A telehealth route and an in-person route can reach the same prescription through different criteria, and the criteria are what generalise.

26 likes 18d

FairweatherTL2Member15 Jul 2026#16

Two sentences on Telehealth prescribing models and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

30 likes 13d

a.stephanopoulosTL3Regular18 Jul 2026#20

Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end.

That is all the detail I have. Someone else will have more.

22 likes 9d

k.roosTL222 Jul 2026#24

e.lokken, post #10: On post #6 — agreed on the reasoning, with one qualification. A telehealth route and an in-person route can reach the same prescription through different criteria, and the criteria are what generalise. Go to post

Answering the Telehealth prescribing models question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken.

30 likes in reply to #10 6d

Read the full topic (31 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
About the North America category Regional › North America FDA compounding insurance Pinned Wiki US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…	+3	7	43k	9mo
Second pass at: Coverage in the US: a map of the usual obstacles Regional › North America insurance telehealth compounding FDA On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…		4	62k	9mo
Canadian access and provincial variation Regional › North America compounding telehealth FDA insurance Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…	+74	80	7.7k	18mo
State-level differences that actually matter Regional › North America compounding telehealth insurance FDA Solved On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. The question about state-level differences that I actually want answered is the second one…	+6	10	56k	10mo
Coverage in the US: a map of the usual obstacles Regional › North America FDA insurance telehealth compounding Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…	+46	50	7.9k	5mo

Related topics — sharing the tags telehealth, FDA, compounding

Topic	Participants	Replies	Views	Activity
Follow-up: External review after an internal denial Access › Insurance & coverage prior authorisation formulary insurance Solved Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. Proposing that External review deserves a maintained page rather than a…	+6	10	12k	15h
Cost per milligram, computed honestly across formats — the long version Access › Pricing cost per milligram compounding formulary data table Cost per milligram, computed honestly across formats — the long version Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because…	+111	124	24k	14mo
Prescription portability between countries Access › International personal import MHRA telehealth EMA Wiki Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries directly, because I have read four…	+104	114	6.1k	3h
Manufacturer assistance programmes and their eligibility rules Access › Pricing formulary data table compounding On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. I have spent a fortnight trying to pin manufacturer assistance programmes…	+37	42	32k	11d
Personal import allowances, compared — a second dataset Access › International personal import telehealth MHRA EMA Wiki Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…	+124	132	9.2k	2mo